Aubrey Capital Management Ltd Purchases Shares of 62,500 Doximity, Inc. $DOCS

Aubrey Capital Management Ltd purchased a new position in Doximity, Inc. (NASDAQ:DOCSFree Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 62,500 shares of the company’s stock, valued at approximately $4,572,000. Doximity makes up approximately 1.4% of Aubrey Capital Management Ltd’s portfolio, making the stock its 18th biggest position.

Other large investors have also modified their holdings of the company. Root Financial Partners LLC purchased a new position in shares of Doximity in the 3rd quarter valued at approximately $30,000. Hantz Financial Services Inc. increased its stake in Doximity by 148.9% during the 2nd quarter. Hantz Financial Services Inc. now owns 453 shares of the company’s stock valued at $28,000 after purchasing an additional 271 shares in the last quarter. Toth Financial Advisory Corp raised its holdings in shares of Doximity by 150.0% in the third quarter. Toth Financial Advisory Corp now owns 500 shares of the company’s stock worth $37,000 after buying an additional 300 shares during the last quarter. First Horizon Corp acquired a new stake in shares of Doximity during the third quarter worth $58,000. Finally, Farther Finance Advisors LLC grew its holdings in shares of Doximity by 196.1% during the third quarter. Farther Finance Advisors LLC now owns 1,134 shares of the company’s stock valued at $83,000 after buying an additional 751 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Analyst Upgrades and Downgrades

DOCS has been the topic of several research reports. Bank of America raised Doximity from a “neutral” rating to a “buy” rating and upped their target price for the company from $75.00 to $82.00 in a research report on Monday, October 27th. Evercore ISI reissued an “outperform” rating on shares of Doximity in a report on Thursday, January 8th. Wells Fargo & Company upgraded Doximity from an “equal weight” rating to an “overweight” rating and reduced their price objective for the stock from $65.00 to $55.00 in a research note on Tuesday. Raymond James Financial reiterated a “strong-buy” rating on shares of Doximity in a research report on Monday, December 29th. Finally, JPMorgan Chase & Co. reiterated an “underweight” rating and issued a $62.00 price target on shares of Doximity in a report on Friday, October 10th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Doximity currently has an average rating of “Moderate Buy” and an average price target of $65.74.

View Our Latest Research Report on DOCS

Doximity Price Performance

Shares of NASDAQ DOCS opened at $39.85 on Thursday. The stock has a market capitalization of $7.50 billion, a price-to-earnings ratio of 39.85, a PEG ratio of 4.10 and a beta of 1.39. Doximity, Inc. has a 12 month low of $39.50 and a 12 month high of $85.21. The firm’s 50 day simple moving average is $45.67 and its 200-day simple moving average is $58.70.

Doximity (NASDAQ:DOCSGet Free Report) last posted its earnings results on Thursday, November 6th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.07. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same period in the previous year, the company posted $0.30 earnings per share. The business’s revenue for the quarter was up 23.2% on a year-over-year basis. Analysts anticipate that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Kira Scherer Wampler sold 2,000 shares of the firm’s stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $66.44, for a total transaction of $132,880.00. Following the sale, the director directly owned 19,839 shares in the company, valued at $1,318,103.16. This trade represents a 9.16% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 31.30% of the stock is currently owned by insiders.

Doximity Company Profile

(Free Report)

Doximity, Inc, headquartered in San Francisco, California, operates the leading professional medical network for healthcare professionals in the United States. Founded in 2011 by Jeff Tangney and Shari Buck, the company set out to create a secure digital environment where physicians, nurse practitioners and physician assistants can collaborate, share information and stay current with clinical news. Doximity went public in June 2021 and trades on the NASDAQ under the ticker symbol “DOCS.”

The core offering of Doximity is its HIPAA-compliant communication platform, which includes a secure messaging system, digital fax services and telehealth capabilities.

Recommended Stories

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.